Navigation Links
Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
Date:10/5/2007

m (n=3,920), cases of

rash, some of which were severe, accompanied by myalgia, fever,

erythema, desquamation, and mucosal erosions were reported.

Discontinue and initiate appropriate treatment if severe skin rash

develops.

-- APTIVUS should be used with caution in patients with a known

sulfonamide allergy.

-- New onset diabetes mellitus, exacerbation of pre-existing diabetes

mellitus, hyperglycemia and increased bleeding (in patients with

hemophilia) have been reported in patients taking protease inhibitors.

A causal relationship between protease inhibitors and these events has

not been established.

-- Immune reconstitution syndrome has been reported in patients treated

with combination antiretroviral therapy, including APTIVUS/r.

-- Redistribution and/or accumulation of body fat have been observed in

patients receiving antiretroviral therapy. A causal relationship has

not been established.

-- Treatment with APTIVUS/r has resulted in large increases in total

cholesterol and triglycerides, which should be monitored prior to and

during APTIVUS/r therapy.

-- Because the potential for HIV cross-resistance among protease

inhibitors has not been fully explored in APTIVUS/r-treated patients,

it is unknown what effect therapy with APTIVUS will have on the

activity of subsequently administered protease inhibitors.

-- APTIVUS must be co-administered with 200 mg of ritonavir to exert its

therapeutic effect. Failure to correctly co-administer APTIVUS with

ritonavir will result in reduced plasma levels of tipranavir that will

be insufficient to achieve the desired antiviral effect and will alter

some drug interactions.

-- Please refer to the complete ritonavir prescribing information for a

description of ritonavir contraindications and
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
2. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
3. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...
(Date:5/21/2013)...  BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC ... stem cell based therapies for various personal applications, announced ... and CEO, will be presenting at the Marcum MicroCap ... on Thursday, May 30, 2013 at the Grand Hyatt ... York City.  Mr. Weinreb,s presentation will take place at ...
(Date:5/21/2013)... SAN DIEGO , May 21, 2013 /PRNewswire/ ... from a secondary analysis of its double-blind, randomized, ... CERE-120 is a gene therapy product designed to ... This exploratory analysis identified a more robust response ... years prior to treatment relative to those diagnosed ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
... 30 Although last year,s flu season was marked ... associated vaccine shortages, pharmacy experts at Cardinal Health expect ... 2010-2011 flu season. The upcoming 2010-2011 flu ... Advisory Committee on Immunization Practices (ACIP) has issued a ...
... YORK, Sept. 30 Reportlinker.com announces that a new market ... Drug Patent Inventor Report 2010 ... Report profiles the individuals, US states, and countries leading pharmaceutical ... to 2009, this report provides complete lists of: ...
Cached Medicine Technology:Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 2Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 3Cardinal Health Helps Health Care Providers Prepare for 2010-2011 Flu Season 4Reportlinker Adds Drug Patent Inventor Report 2010 2
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... be at increased risk of suffering depression after giving ... hope they can use the findings to develop a ... are vulnerable to postpartum depression, which affects around 15 ... the May 21 issue of the journal Molecular ...
(Date:5/21/2013)... 2013 Pathways Home Health, Hospice ... to remember and honor a loved one in the ... Service, Sunday, June 2, 2013, 3-4 pm at Skylawn ... Mateo, CA 94402. , The Pathways Hospice Evening of ... program with music, readings and support. Open to the ...
(Date:5/21/2013)... patients are significantly more likely than their normal-weight ... practice that disrupts continuity of care and leads ... research suggests. , The practice of "doctor shopping" ... negative experiences with the health care system, whether ... weight loss advice by providers, or improperly sized ...
(Date:5/21/2013)... 2013 STAR (Sensory Therapies And ... with sensory challenges and the Sensory Processing Disorder ... and advocacy of Sensory Processing Disorder present Stumbling Blocks ... Improve Quality of Life, a two-hour lecture presented by ... , Learn a method that can aid in ...
(Date:5/21/2013)... Diehard soccer fans will definitely want to ... the game between Manchester City and Chelsea FC ... These two teams are highly decorated in the English Premiere ... to the Busch Stadium, home of the St. Louis Cardinals, ... time that a professional sporting event and non-baseball game will ...
Breaking Medicine News(10 mins):Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2
... -- A reduction by half in the radiation dose ... imaging is now "feasible", according to an Israeli study. ... a late-breaking trial at the International Conference of Non-Invasive ... now one of the world,s major scientific events in ...
... Reporter , MONDAY, May 16 (HealthDay News) -- A new ... lowered ability to remember lists of words, although the research ... fine on a separate memory test. It,s not clear ... have any impact on the ability of college students to ...
... prostate cancer that measures levels of prostate specific antigen (PSA) ... of men with the disease was more sensitive and more ... a study by researchers at UCLA,s Jonsson Comprehensive Cancer Center. ... rate of false-positives, tests that indicate the presence of cancer ...
... , MONDAY, May 16 (HealthDay News) -- In men who,ve ... smoking seems linked to a rise in blood levels of ... of cancer recurrence. So finds a new study slated ... American Urological Association (AUA) in Washington, D.C. The ...
... May 16 (HealthDay News) --,More than half of those who ... misdiagnosed when the first signs of the disease are symptoms ... researchers reviewed the cases of 40 people from Barcelona who ... also reviewed information about the age at which the symptoms ...
... by the Institute of Medicine explored what is necessary ... full potential of new digital technologies such as tablets ... knowledge to real-time care decisions. , Digital Infrastructure for ... in Health and Health Care recaps presentations and discussions ...
Cached Medicine News:Health News:Halving the radiation dose in cardiac perfusion imaging is now 'feasible' 2Health News:Halving the radiation dose in cardiac perfusion imaging is now 'feasible' 3Health News:Binge Drinking Tied to Memory Loss in College Students: Study 2Health News:New prostate cancer test more specific, sensitive than PSA test 2Health News:New prostate cancer test more specific, sensitive than PSA test 3Health News:Research Shows Early Onset Alzheimer's Disease Sometimes Missed 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: